Upstream Bio, Inc.
UPB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $683 | $937 | $566 | $613 |
| % Growth | -27.1% | 65.5% | -7.7% | – |
| Cost of Goods Sold | $31 | $0 | $0 | $0 |
| Gross Profit | $652 | $937 | $566 | $613 |
| % Margin | 95.5% | 100% | 100% | 100% |
| R&D Expenses | $32,975 | $37,865 | $25,797 | $21,773 |
| G&A Expenses | $0 | $7,419 | $6,782 | $5,158 |
| SG&A Expenses | $5,511 | $7,419 | $6,782 | $5,158 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $38,486 | $45,284 | $32,579 | $26,931 |
| Operating Income | -$37,834 | -$44,347 | -$32,013 | -$26,318 |
| % Margin | -5,539.4% | -4,732.9% | -5,656% | -4,293.3% |
| Other Income/Exp. Net | $4,086 | $4,381 | $4,743 | $5,076 |
| Pre-Tax Income | -$33,748 | -$39,966 | -$27,270 | -$21,242 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$33,748 | -$39,966 | -$27,270 | -$21,242 |
| % Margin | -4,941.1% | -4,265.3% | -4,818% | -3,465.3% |
| EPS | -0.63 | -0.74 | -0.51 | -0.41 |
| % Growth | 14.9% | -45.1% | -24.4% | – |
| EPS Diluted | -0.63 | -0.74 | -0.51 | -0.41 |
| Weighted Avg Shares Out | 53,931 | 53,771 | 53,618 | 51,342 |
| Weighted Avg Shares Out Dil | 53,931 | 53,771 | 53,618 | 51,342 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4,105 | $4,431 | $4,743 | $5,076 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $31 | $42 | $43 | $49 |
| EBITDA | -$33,717 | -$44,305 | -$31,970 | -$26,269 |
| % Margin | -4,936.6% | -4,728.4% | -5,648.4% | -4,285.3% |